Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT01972347
What this trial is testing

Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 35
Testing effectiveness (Phase 2)Study completedNCT03341143
What this trial is testing

Fecal Microbiota Transplant (FMT) in Melanoma Patients

Who this might be right for
Melanoma
Zarour, Hassane, MD 20
Testing effectiveness (Phase 2)Study completedNCT00004184
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Alabama at Birmingham 50
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Not applicableNot Yet RecruitingNCT07046728
What this trial is testing

Efficay and Safety of DAROMUN on Patient Treated by Intralesionnal Injection: DAROMEL

Who this might be right for
Injections Intralesional
Centre Hospitalier Universitaire de Nice 70
Testing effectiveness (Phase 2)Ended earlyNCT03301636
What this trial is testing

Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
NewLink Genetics Corporation 21
Testing effectiveness (Phase 2)Ended earlyNCT01944709
What this trial is testing

Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma

Who this might be right for
Melanoma
Prof. Dr. Silke Gillessen 2
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT01682213
What this trial is testing

Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT02872259
What this trial is testing

BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma

Who this might be right for
Melanoma
Haukeland University Hospital 74
Testing effectiveness (Phase 2)Study completedNCT01883323
What this trial is testing

Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma

Who this might be right for
Metastatic, Stage III or Stage IV, Melanoma
University Health Network, Toronto 12
Not applicableStudy completedNCT00897520
What this trial is testing

Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 40
Large-scale testing (Phase 3)Study completedNCT02843386
What this trial is testing

Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

Who this might be right for
Uveal Melanoma
Institut Curie 302
Large-scale testing (Phase 3)Study completedNCT01006980
What this trial is testing

Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 675
Testing effectiveness (Phase 2)Ended earlyNCT00601861
What this trial is testing

Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer

Who this might be right for
CancerMalignant Melanoma
Novo Nordisk A/S 1
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableStudy completedNCT02439411
What this trial is testing

Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain

Who this might be right for
Malignant Melanoma Stage IVMalignant Melanoma Stage IIIc
Grupo Español Multidisciplinar de Melanoma 135
Testing effectiveness (Phase 2)Study completedNCT00060333
What this trial is testing

Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma

Who this might be right for
Recurrent Melanoma
Alliance for Clinical Trials in Oncology 20
Early research (Phase 1)Not Yet RecruitingNCT07581509
What this trial is testing

Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma

Who this might be right for
Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings)
Biocon Biologics UK PLC 138
Next Page